FIFTH THIRD BANCORP - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 185 filers reported holding TG THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.

Quarter-by-quarter ownership
FIFTH THIRD BANCORP ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$10,910
-90.4%
1,305
-71.4%
0.00%
-100.0%
Q2 2023$113,494
+65.2%
4,5690.0%0.00%
Q1 2023$68,718
+27.1%
4,5690.0%0.00%
Q4 2022$54,051
+100.2%
4,5690.0%0.00%
Q3 2022$27,000
+42.1%
4,569
+813.8%
0.00%
Q2 2021$19,000
-48.6%
500
-92.4%
0.00%
Q3 2018$37,000
-57.5%
6,6000.0%0.00%
-100.0%
Q2 2018$87,0006,6000.00%
Other shareholders
TG THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
M28 Capital Management LP 726,200$3,086,0003.46%
Paradigm Biocapital Advisors LP 1,964,709$8,350,0001.66%
683 Capital Management, LLC 3,300,000$14,025,0000.99%
MAVERICK CAPITAL LTD 6,747,549$28,677,0000.71%
Antara Capital LP 1,500,000$6,375,0000.27%
Parkwood LLC 47,168$1,375,0000.24%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,677,500$11,379,0000.24%
PURA VIDA INVESTMENTS, LLC 950,813$4,041,0000.24%
OCCUDO QUANTITATIVE STRATEGIES LP 567,576$2,412,0000.20%
Antara Capital LP 900,000$3,825,0000.16%
View complete list of TG THERAPEUTICS INC shareholders